Banyan Corp (BNYN)
Banyan Corp. is an OTC Markets-listed common stock of a company operating through subsidiaries in the healthcare services field. The business focuses on franchising chiropractic clinics across North America and supports chiropractors and franchisees with practice development training, operational assistance, and related franchise services. It also provides diagnostic testing services, including nerve conduction velocity testing used by health care professionals to assess nerve function and help identify nervous system disorders. In addition, Banyan manufactures and markets the VT3000, a nerve testing system used in evaluating neuropathies and other nerve-related conditions. The company was founded in 1978 and is based in Beverly Hills, California.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-BNYN
|
—
|
—
|
—
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
1.505 K
|
—
|
—
|
—
|
—
|
—
|
—
|